Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • The added value of concomitant...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
The added value of concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in patients with prostate cancer diagnosed by MRI-targeted biopsy

The added value of concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in patients with prostate cancer diagnosed by MRI-targeted biopsy

Show other versions (1)
Bibliographic Details
Main Authors: A. Rizzo, G. Gandaglia, G. Ploussard, M. Valerio, A. Mattei, G. Marra, J. Beauval, B. Malavaud, M. Roumiguiè, A. Marquis, N. Fossati, F. Scalvi, D. Robesti, A. Stabile, L. Afferi, M. Moschini, A. Rakauskas, R. Van Der Bergh, F. De Cobelli, C. Fiori, F. Porpiglia, P. Gontero, F. Montorsi, A. Briganti
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320353854
  • Holdings
  • Description
  • Other Versions (1)
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320353854

Similar Items

  • The added value of concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in patients with prostate cancer diagnosed by MRI-targeted biopsy
    by: G. Gandaglia, et al.
    Published: (2020-07-01)
  • Can we improve our ability to assess primary tumor stage of prostate cancer in patients with MRI-visible lesions? development and external validation of a novel T-stage classification based on clinical and MRI findings
    by: L. Nocera, et al.
    Published: (2020-10-01)
  • When is mp-MRI reliable in predicting extra-prostatic extension in prostate cancer patients treated with radical prostatectomy? Results from a large, multi-institutional series
    by: G. Gandaglia, et al.
    Published: (2020-07-01)
  • Can multiparametric MRI improve our ability to predict early biochemical recurrence after radical prostatectomy in contemporary patients? Results from a multi-institutional analysis
    by: G. Gandaglia, et al.
    Published: (2020-07-01)
  • Can multiparametric MRI improve our ability to predict early biochemical recurrence after radical prostatectomy in contemporary patients? results from a multi-institutional analysis
    by: A. Rizzo, et al.
    Published: (2020-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs